Literature DB >> 23863471

Of diabetic mice and ACE2: a new biomarker of renal disease?

Mark C Chappell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23863471      PMCID： PMC3798742          DOI： 10.1152/ajprenal.00403.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN： 1522-1466


× No keyword cloud information.
  14 in total

1.  Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.

Authors:  Hossam A Shaltout; Brian M Westwood; David B Averill; Carlos M Ferrario; Jorge P Figueroa; Debra I Diz; James C Rose; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2006-08-08

2.  Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach.

Authors:  Alexandre Lautrette; Shunqiang Li; Rohia Alili; Susan W Sunnarborg; Martine Burtin; David C Lee; Gérard Friedlander; Fabiola Terzi
Journal:  Nat Med       Date:  2005-07-24       Impact factor: 53.440

3.  Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications.

Authors:  Aino Soro-Paavonen; Daniel Gordin; Carol Forsblom; Milla Rosengard-Barlund; Johan Waden; Lena Thorn; Niina Sandholm; Merlin C Thomas; Per-Henrik Groop
Journal:  J Hypertens       Date:  2012-02       Impact factor: 4.844

4.  ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

Authors:  M J Soler; J Wysocki; M Ye; J Lloveras; Y Kanwar; D Batlle
Journal:  Kidney Int       Date:  2007-06-20       Impact factor: 10.612

Review 5.  Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.

Authors:  Shigeki Higashiyama; Hidehiko Iwabuki; Chie Morimoto; Miki Hieda; Hirofumi Inoue; Natsuki Matsushita
Journal:  Cancer Sci       Date:  2008-02       Impact factor: 6.716

6.  Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats.

Authors:  Ibrahim F Benter; Mariam H M Yousif; Gursev S Dhaunsi; Jaspal Kaur; Mark C Chappell; Debra I Diz
Journal:  Am J Nephrol       Date:  2007-09-20       Impact factor: 3.754

7.  ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes.

Authors:  Chris Tikellis; Katarzyna Bialkowski; Josepha Pete; Karen Sheehy; Qui Su; Colin Johnston; Mark E Cooper; Merlin C Thomas
Journal:  Diabetes       Date:  2008-01-30       Impact factor: 9.461

8.  Regulation of urinary ACE2 in diabetic mice.

Authors:  Jan Wysocki; Laura Garcia-Halpin; Minghao Ye; Christoph Maier; Kurt Sowers; Kevin D Burns; Daniel Batlle
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

9.  Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia.

Authors:  Hong Peng Jia; Dwight C Look; Ping Tan; Lei Shi; Melissa Hickey; Lokesh Gakhar; Mark C Chappell; Christine Wohlford-Lenane; Paul B McCray
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-01       Impact factor: 5.464

10.  Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

Authors:  Daniel W Lambert; Mike Yarski; Fiona J Warner; Paul Thornhill; Edward T Parkin; A Ian Smith; Nigel M Hooper; Anthony J Turner
Journal:  J Biol Chem       Date:  2005-06-27       Impact factor: 5.157
View more
  2 in total

1.  Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice.

Authors:  Hari K Somineni; Gregory P Boivin; Khalid M Elased
Journal:  J Endocrinol       Date:  2014-04-22       Impact factor: 4.286

2.  Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.

Authors:  Jan Wysocki; Minghao Ye; Ahmed M Khattab; Agnes Fogo; Aline Martin; Nicolae Valentin David; Yashpal Kanwar; Mark Osborn; Daniel Batlle
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.